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The aim of the study was to estimate and to compare effective doses in the elbow
region resulting from four different x-ray imaging modalities. Absorbed organ doses
were measured using 11 metal oxide field effect transistor (MOSFET) dosimeters
that were placed in a custom-made anthropomorphic elbow RANDO phantom.
Examinations were performed using Shimadzu FH-21 HR radiography device, Sie-
mens Sensation Open 24-slice MSCT-device, NewTom 5G CBCT device, and Plan-
med Verity CBCT device, and the effective doses were calculated according to ICRP
103 recommendations. The effective dose for the conventional radiographic device
was 1.5 µSv. The effective dose for the NewTom 5G CBCT ranged between 2.0
and 6.7 µSv, for the Planmed Verity CBCT device 2.6 µSv and for the Siemens Sen-
sation MSCT device 37.4 µSv. Compared with conventional 2D radiography, this
study demonstrated a 1.4–4.6 fold increase in effective dose for CBCT and 25-fold
dose for standard MSCT protocols. When compared with 3D CBCT protocols, the
study showed a 6-19 fold increase in effective dose using a standard MSCT proto-
col. CBCT devices offer a feasible low-dose alternative for elbow 3D imaging when
compared to MSCT.
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1 | INTRODUCTION
A fall onto an outstretched arm is a typical cause for radial head
fractures.1,2 Such traumatic injuries are particularly common in chil-
dren and adults who engage in sports activities.3,4 To date, conven-
tional radiographs play a major role in primary elbow diagnostics
comprising anterior-posterior (AP) and lateral (LAT) projections.5
However, it must be noted that complex fractures are often difficult
to visualize using two-dimensional (2D) radiographic images where
skeletal objects may become superimposed by adjacent bony struc-
tures.6 In such cases, multi slice radiographs need to be acquired
using computed tomography (CT) to provide highly detailed 3D
information on occult and other complex fractures.7 Furthermore,
multi-slice computed tomography devices (MSCT) provide all the
necessary diagnostic information that previously required two or
more 2D projections.8 However, a major drawback resulting from
MSCT examinations is that they are often associated with a signifi-
cantly higher radiation dose than conventional 2D transmission
radiography.9 Another challenge faced when using MSCT for elbow
examinations is the additional radiation dose to other body parts. In
order to minimize excessive radiation dose, the internal organs of
the body the arm should not be positioned adjacent to the body.
Respectively, if the arm is extended upward, a part of the head may
become irradiated by the primary or scattered radiation increasing
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the effective dose to the brain and to the bone marrow dose in the
calvaria.10,11
In recent years, cone beam computed tomography (CBCT) tech-
nology has found a new application for imaging extremities,12 thus
offering a versatile alternative to MSCT devices. In clinical settings,
CBCT images are particularly useful in detecting subtle and non-dis-
placed radial head fractures and for staging of intra-articular frac-
tures with entrapment of fragments within the elbow joint.13 The
key benefits of CBCT technology are that they perform high-resolu-
tion imaging of the extremities using less time than radiographs and
multi-detector computed tomography (MDCT) and lower radiation
dose than MDCT.14–16 Furthermore, CBCT images of extremities
(arms/legs) can be undertaken without irradiating other body parts.
Regardless of the x-ray examination modality, radiation dose is
always present, and the diagnostic benefits of all examinations
should be weighed against the radiation risk that they induce. To the
best of the authors’ knowledge, there are currently no contempora-
neous studies involving the x-ray radiation risk in the elbow region.
Therefore, the aims of this study were to assess and compare the
organ and effective doses in the elbow resulting from conventional
radiography, MSCT, and two CBCT devices using manufacturer-rec-
ommended elbow protocols.
2 | MATERIALS AND METHODS
2.A | X-ray devices
Absorbed organ doses were measured using a conventional high-res-
olution direct digital radiographic device (model FH-21 Shimadzu
Corporation, Kyoto, Japan), a 24-slice MSCT device (model Sensa-
tion, Siemens, Forchheim, Germany), and two CBCT devices: (model
NewTom 5G®, QR, Verona, Italy and model Verity, Planmed Oy, Hel-
sinki, Finland).
In order to perform effective and absorbed dose comparisons, the
field of view (FOV) of the conventional radiographic device and the
MSCT scanner were chosen to match the FOV (13 cm × 16 cm) of the
Planmed Verity CBCT scanner. The Planmed Verity radiation doses
were assessed using the novel “Ultra Low Dose” (ULD) protocol, the
NewTom 5G “Standard Scan” setting radiation dose was measured
using three different FOVs (12 cm × 8 cm, 15 cm × 12 cm, 18 cm ×
16 cm), and for the “HiRes” setting, the dose was measured using a
12 cm × 8 cm FOV. Since the diagnosis of elbow fractures is commonly
based on AP and LAT projections, the sum of the doses obtained using
the 2D projections served as a benchmark for the dose comparisons.
The exposure settings used in this study were based on a publi-
cation by Huang et al.14 In their study, Huang et al. compared effec-
tive dose values with corresponding image quality in the elbow
region using a CBCT and MSCT device (Planmed Verity CBCT:
(75–96 kVp, 3.8–12 mA, Philips and GE MDCT devices: 120 kVp,
200 mAs). (Table 1). The NewTom 5G device, however, uses a fixed
110 kVp tube voltage and automatically adjusted mA value based on
two scout images of the region of interest (Table 1). The source-to-
detector distance remained unchanged during the scanning
procedure. However, the cone beam angle of the NewTom 5G scan-
ner varied between 10.3 (small FOV) and 15.4 degrees (large FOV)
between the different FOVs. (Table 5.)
2.B | Phantom
All organ radiation dose measurements were performed using a
specifically designed anthropomorphic RANDO adult arm phantom
(Radiation Analogue Dosimetry System; The Phantom Laboratory,
Salem, NY, USA). The phantom contains human bones that were
encased within a soft tissue equivalent material to make the phan-
tom match the radiation scattering and attenuation properties of the
human elbow. The full arm phantom was sliced into 24 detachable
layers that were numbered from 1 to 24 from the tip of the fingers
to the upper arm (Fig. 1).
The layers were 25-mm thick and had a 1.5 cm × 1.5 cm grid of
5-mm diameter holes for the placement of MOSFET dosimeters.
Each dosimeter void was factory fitted with a soft tissue equivalent
plug that allowed the correct positioning of 11 MOSFET dosimeters.
Figure 2 shows a typical setup of an anthropomorphic elbow phan-
tom loaded with MOSFET dosimeters that is positioned into the
bore of a CBCT device.
2.C | Dosimeters
2.C.1 | Reference dosimeter
Before putting the MOSFET dosimeters into use, they were cali-
brated using a RADCAL 1015 dosimeter equipped with RADCAL
10X5-6 ionization chamber (Radcal Corporation, Monrovia, CA,
USA). The calibration chain is traceable to primary dosimetry labora-
tory (PSDL) via the secondary dosimetry laboratory (SSDL) at the
Finnish Radiation and Nuclear Safety Laboratory. Prior to making the
measurements, all 11 MOSFET dosimeters were calibrated for pho-
ton energy response, dose dependency, uncertainty, and angular
sensitivity divergences according to the protocols presented in previ-
ous studies by Koivisto et al.16–18
2.C.2 | MOSFET dosimeters
The absorbed radiation doses required for the effective dose calcula-
tions were measured using a mobile TN-RD-70-W20 MOSFET device.
The measurement system comprises 11 reinforced high-sensitivity
TN-1002RD-H dosimeters, three TN-RD-16 reader modules, and TN-
RD-75 M software (Best Medical, Ottawa, ON, Canada). The MOSFET
device uses a TN-RD-38 wireless Bluetooth transceiver to transfer the
data to a computer where the MOSFET dosimeter initializations and
dose registrations are performed. The MOSFET dosimeter sensitivity
can be selected using a switch on the reader device for high or low
bias voltage that subsequently provides high or low sensitivity, respec-
tively. In this study, the high sensitivity setting was applied to attain
the best accuracy and to minimize dose related inaccuracies.
All 11 MOSFET dosimeters were positioned in predrilled voids
located in the layers (11 to 17) of the phantom that covered the
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most radiosensitive organs (Table 2, Fig. 3).19 The highest contribu-
tor to the effective dose in extremities is bone marrow.16,20,21
Therefore, one dosimeter was placed within the bone (humerus,
radius) in each layer to attain accurate dose detection and to provide
a means to evaluate the dose uniformity amongst the different x-ray
modalities. The remaining dosimeters were used to measure the skin,
bone surface, muscle and lymphatic (cubital) nodes.
2.D | Equivalent dose
The equivalent or radiation weighted dose HT of the irradiated tis-




In this equation, wR is the radiation weighting factor (wR = 1 Sv/Gy
for x-rays), fi is the mass fraction of tissue T in phantom layer i, and DTi
is the average absorbed dose of tissue T in layer i. The summation was
performed over all exposed layers (11 to 17). In this study, the mass
fraction (fi) denotes the coverage of each tissue in relative scale com-
pared with the total tissue mass in the corresponding organ in the body
(Table 3.) The studied organs were exposed by the incident and scat-
tered radiation during the examinations. The dosimetric assessment
was, however, performed using similar coverage regardless of the posi-
tioning of the beam to the phantom layers.16







AP+LAT Open "Hi Res"
"Standard Scan"
CBCT
Radiography MSCT 12 × 8 12 × 8 15 × 12 18 × 16 13 × 16
Potential (kV) 59 120 110 110 110 110 92
Tube current (mA)a — 115 5.13 0.97 0.72 0.66 5
Exposure time (s) — 1 5.4 3.6 3.6 3.6 4.5
Q (mA*s) 12.6 115 27.7 3.5 2.6 2.4 22.5
CTDIvol (mGy) — 11.0 4.40 1.16 1.15 1.14 —
DLP (mGy *cm) — 179 39.6 10.5 14.7 18.2 —
Filtration (mm Al eq.) 1.5 6.8 1.4 1.4 1.4 1.4 8.1
Focal size (mm) 1.2 0.7 0.3 0.6 0.6 0.6 0.5
Anode angle (°) 12° 9° 15° 15° 15° 15° 5°
Slice thickness (mm) — 2 — — — — —
Pitch (mm) — 0.5 — — — — —
Voxel H (mm) — — 0.15 0.3 0.3 0.3 0.4
Voxel L (mm) — — 0.15 0.3 0.3 0.3 0.4
Voxel W (mm) — — 0.15 0.3 0.3 0.3 0.4
Scan angle (°) — 360° 360° 360° 360° 360° 210°
Frame number — — 360 360 360 360 300
Scan height (mm) 130 130 80 80 120 160 130
Scan diam. (mm) 160 160 120 120 150 180 160
aFor NewTom 5G CBCT: mA is automatically adjusted by "SafeBeam™" acquisition technique.
F I G . 1 . A schematic illustration of an
anthropomorphic arm phantom with the
exposed field of view.
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2.E | Tissue mass factions
2.E.1 | Bone marrow
Bone marrow (BM) is one of the largest and most radiosensitive tis-
sues in the human body. According to a study by Hindorf et al.,23
the total bone marrow content represents 4% of the total body
weight. However, the active radiosensitive red bone marrow (RBM)
comprises only one-third of the total bone marrow weight.24 In the
present study, the bone marrow volume (cm3) was assessed by mea-
suring the cross section of all bones embedded in the phantom and
multiplying them by the corresponding layer thickness (2.5 cm). The
bone marrow volumes were summed for layers 10 to 17 to obtain
the total bone marrow volume. The RBM weight was subsequently
calculated as one-third of the BM volume multiplied by the density
of red bone marrow.25 Since bone marrow is one of the most
radiosensitive organs, the RBM mass was also calculated based on
data provided by Iwata et al.26 and using the RBM distribution
according to a recent publication by Machann et al.27 According to
both assessment methods the bone marrow in the elbow region rep-
resents 1.0% of the total bone marrow quantity in the human body.
F I G . 2 . Typical setup of an anthropomorphic elbow phantom
placed into the bore of a CBCT device and the MOSFET readers.
TAB L E 2 MOSFET dosimeter locations in anthropomorphic
RANDO elbow phantom.
Dosimeter
no Layer Location Tissue
1 17 Humerus Bone Marrow/Bone surface
2 16 Humerus Bone Marrow/Bone surface
3 16 Triceps brachii Bone surface/Muscle
4 16 Biceps brachii Skin/Muscle
5 15 Humerus Bone marrow/Bone surface
6 14 Cubital nodes/ Bone marrow/Bone surface/
Lymphatic nodes
7 14 Ulna Bone marrow




10 12 Ulna Bone marrow
11 11 Ulna Bone marrow/Bone surface
F I G . 3 . The placement of MOSFET dosimeters in the elbow
phantom [AP (a), LAT (b)].
TAB L E 3 ICRP 103 weighting factors (wT), fractions irradiated (fi),
and and dosimeters used to calculate effective dose.
Organ wT fi Dosim. No.
Bone marrow 0.12
Ulna 0.19% 7, 8, 10, 11
Radius 0.21% 6, 8, 10, 11
Humerus 0.60% 1, 2, 5, 6
Bone surface 0.01
Ulna 0.40% 6, 9
Radius 0.39% 6, 9
Humerus 0.93% 1, 2, 5, 6
Skin 0.01








Cubital nodes 5.00% 6
Muscle







KOIVISTO ET AL. | 131
2.E.2 | Bone surface
The bone surface in the elbow area was calculated using the bone
surface-to-volume ratio according to ICRP Publication 70,25 the per-
centage of total fresh bone weights defined in ICRP Publication 8924
and the irradiated fractions of ulna, radius, and humerus based on
the bone lengths according to a study by Schlenker et al.28 The bone
surface in the exposed region was estimated to represent 1.7% of
the total body bone surface.
2.E.3 | Skin
The skin area was calculated in layers 11 to 17. Each layer perimeter
was multiplied by the 2.5-cm phantom layer thickness and summed to
attain the total skin area. The skin fraction in the elbow region was
estimated by dividing the resulting value by the total skin area calcu-
lated using the Du Bois and Du Bois equation.29 The fraction of skin in
the exposed volume was equivalent to 2.9% of the whole-body skin.
2.E.4 | Remainder tissues
The effective dose contributions of the remainder tissues were cal-
culated according to ICRP Publication 103 recommendations.19 The
elbow region contains only two remainder organs, namely muscles
and lymphatic nodes, also known as cubital nodes.
2.E.5 | Muscles
The total muscle mass was assessed by summing the fraction of
each muscle in the elbow region according to a study by Holzbaur
et al.30 The muscle mass fractions of each muscle were summed for
layers between 11 and 17. The total body muscle mass in the elbow
was calculated by dividing the result by the total 28 000 g body
muscle mass.31,32 It was estimated that muscles in the exposed
region represent 0.9% of the total body muscle mass.
2.E.6 | Lymphatic nodes
The lymphatic node content in the elbow was evaluated using data pub-
lished by Luscieti et al.33 and the results of a whole-body lymphoscintig-
raphy examination performed at the Docrates Cancer Center in Helsinki,
Finland.16 According to the study by Luscieti et al., the adult cubital node
cross section in the elbow region was comparable with the popliteal
fossa cross section located in the knee area. Furthermore, based on the
lymphoscintigraphy, it was estimated that the popliteal fossa in the knee
area contains 5% of the total lymphatic nodes. Since the lymphatic node
content (cubital nodes) in the elbow and knee were comparable, the
same (5%) lymphatic node mass fraction was used.
2.F | Effective dose
The effective dose calculation was performed according to the Inter-
national Commission of Radiological Protection (ICRP) guidelines.19
Although the effective dose is not a physical quantity, it provides a
useful means to assess the stochastic risk between different imaging
techniques and protocols for unevenly distributed organ doses in the
body.21 The effective dose (E) was calculated from measured
absorbed organ doses using the following equation:
E¼∑
T
wT HT , (2)
where wT is the weighting factor of tissue (T) and HT is the equiva-
lent dose in tissue (T). All effective dose contributions were calcu-
lated using their specific fractions irradiated, weighting factors and
adult organ dose compositions).19,33 Furthermore, given that it may
be difficult to compare the effective doses resulting from radiogra-
phy, CBCT and MSCT devices due to the different exposure settings,
their current — exposure time — product (mA * s) normalized effec-
tive doses (µSv/mAs) were calculated (Table 4). The tissue mass frac-
tions (fi) and the ICRP Publication 103 weighting factors wT used in
the calculations are presented in Table 3.
2.G | Uncertainty analysis
The characterization involved the uncertainty of 11 individual
dosimeters that were accounted for in this study. The absorbed dose
uncertainty of a MOSFET dosimeter depends on the amount of dose
exposure18 and due to the statistical nature, on the number of sam-
ples that were used for averaging. The type A standard absorbed
dose (1SD) uncertainty (uA) was calculated from the 11 dosimeter
uncertainties using quadratic summation of the average value of 10
repeated measurements according to a previous study by Koivisto
et al.16 The combined type B uncertainty was calculated from the
quadratic summation of all estimated uncertainties.
3 | RESULTS
3.A | Conventional radiography device
The effective doses resulting from the Shimadzu FH-21 HR radio-
graphic device were 0.5 µSv for AP and 1.0 µSv for the LAT view
(AP + LAT 1.5 µSv). The highest contributor to the effective dose
was bone marrow (43%) followed by lymphatic nodes (28%), skin
(17%), bone surface (7%), and muscles (4%).
3.B | MSCT device
The effective dose obtained using Siemens Sensation Open MSCT
device was 37.4 µSv. The major contributors to the effective dose
were bone marrow (51%), lymphatic nodes (23%), skin (15%), bone
surface (7%), and muscles (4%).
3.C | CBCT devices
The effective dose acquired using NewTom 5G device (12 cm × 8 cm
FOV) and “Standard Scan” setting was 2.0 µSv, and for the “HiRes”
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setting the effective dose was 6.7 µSv. The contributors to the effec-
tive dose for both dose settings were: bone marrow (50%), lymphatic
nodes (29%), skin (11%), bone surface (6%), and muscles (4%). Using
the 15 cm × 12 cm FOV with the “Standard Scan” setting resulted in
an effective dose of 2.5 µSv. The contributors to the effective dose
originated from bone marrow (50%), lymphatic nodes (28%), skin
(12%), bone surface (6%), and muscle (4%). Using the 18 cm × 16 cm
FOV, the NewTom 5G resulted in an effective dose of 2.1 µSv, and
the effective dose contributions were bone marrow (48%), lymphatic
nodes (26%), skin (15%), bone surface (7%), and muscle (5%).
The effective dose attained using Planmed Verity CBCT device
was 2.6 µSv. The major contributors to the effective dose for both
protocols were as follows: bone marrow (52%), lymphatic nodes
(23%), skin (14%), bone surface (7%), and muscles (4%).
The effective doses, normalized effective dose (µSv/mAs), effective
dose contributions, and dose comparison with the radiography dose
(normalized to 1) for all protocols are presented in Table 4. The
absorbed organ doses (mGy) and their dose comparisons with the aver-
age dose value of the radiography device are presented in Table 5.
The anterior-posterior projections (cropped images) of the
exposed volume using conventional radiographic, two CBCT, and
MSCT devices are presented in Fig. 4.
3.D | Uncertainty, effective and organ doses
The type A standard uncertainty of the absorbed dose for all protocols
varied between 15% and 48% in the 11 dosimeters. The uncertainties of
point dose measurements were calculated as weighted sum of variances
and included the statistical measurement error of ten repeated measure-
ments according to a previous study,34 dosimeter- and phantom position
uncertainties, (10% and 10% respectively), x-ray source variation (5%)
and cable irradiation uncertainties (1%).35 The tissue dose uncertainty
depended on the dosimeter uncertainty and the estimated fraction of
irradiated fi (25%).
The Type B effective dose uncertainties (1SD, 2SD) were calculated
as weighted sum of variances of bone marrow, bone surface, skin, and
remainder tissues. The uncertainty (1SD and expanded 2SD) results
were as follows: Shimadzu (14%, 28%), Siemens Sensation Open (12%,
24%), Planmed Verity (13%, 26%), NewTom 12 cm × 8 cm “HiRes”
(14%, 29%) and for NewTom “Standard Scan”: 12 cm × 8 cm (15%,
30%), 15 cm × 12 cm (14%, 28%), 18 cm × 16 cm (13%, 26%).
4 | DISCUSSION
In this paper, the absorbed and effective doses in the elbow region
were evaluated on one radiographic device, two CBCT devices and
one MSCT device. Two-dimensional radiography typically consists of
AP and LAT projections and is the most commonly used diagnostic
imaging method in the elbow area. Therefore, the effective dose
resulting from radiography projections was used as a benchmark for
the dose comparison.
4.A | Effective dose
The concept of effective dose was first introduced in 1977 to assess
stochastic health effects of radiation in medicine.36 Since the intro-
duction of effective dose, there has been an ongoing debate about
its suitability for dose assessment due to the uncertainties in the
conversion coefficients that are used to calculate the tissue weight-
ing factors.37 Regardless of the drawbacks, effective dose is, how-
ever, the only means used to assess and compare the risk of health
detriment and was therefore chosen for this study.38 However,
according to Fisher et al.39 the individual assessment of potential
detriment should be based on organ or tissue absorbed radiation
dose. Therefore, the measured absorbed organ doses of each proto-
col were also included in this study for dose comparison. The effec-
tive dose ratios (Table 4) and the absorbed organ dose ratios of the








AP+LAT Open "Hi Res"
"Standard Scan"
CBCT
Radiography MSCT 12 × 8 12 × 8 15 × 12 "18 × 16" 13 × 16
Bone marrow 0.6 19.0 3.4 1.0 1.2 1.0 1.3
Bone surface 0.1 2.7 0.4 0.1 0.2 0.1 0.2
Skin 0.2 5.5 0.8 0.2 0.3 0.3 0.4
Remainder
Lymphatic nodes 0.4 8.5 2.0 0.6 0.7 0.5 0.6
Muscle 0.1 1.6 0.2 0.1 0.1 0.1 0.1
Effective dose 1.5 37.4 6.7 2.0 2.5 2.1 2.6
Norm.E (µSv/mAs)a 0.12 0.32 0.24 0.58 0.95 0.86 0.11
Effective dose ratiob 1.0 25.4 4.6 1.4 1.7 1.4 1.8
aExposure unit (mAs) normalized effective dose.
bDose compared to the radiographic device.
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corresponding protocol mean absorbed doses (Table 5) have an
excellent correlation (0.9999).
4.B.1 | Effective dose comparison
The highest effective dose (37.4 µSv) was attained on the Siemens
Sensation MSCT device. The effective dose was 25.4 times the
effective dose measured on the 2D radiographic device (1.5 µSv). In
contrast, the NewTom 5G CBCT effective dose was only 1.4 times
the dose attained on the 2D radiographic device using the “Standard
Scan” settings 12 cm × 8 cm FOV (2.0 µSv). Using the same FOV
(12 × 8 cm) and the “HiRes” setting on the New Tom device, the
effective dose was markedly higher (6.7 µSv) and was 4.6 times the
dose of the radiographic device. When using the “Standard Scan”
setting, the effective doses were 2.5 µSv for 15 cm × 12 cm FOV
and 2.1 µSv for 18 cm × 16 cm FOV being 1.7 and 1.4 times the








AP+LAT Open "Hi Res"
"Standard Scan"
CBCT
Radiography MSCT 12 × 8 12 × 8 15 × 12 18 × 16 13 × 16
1 Humerus 0.3 11.5 0.3 0.1 0.5 0.5 0.3
2 Humerus 0.5 17.1 2.9 0.9 0.8 1.0 1.3
3 Triceps brachii 0.6 18.8 1.5 0.5 1.1 1.1 1.4
4 Bicep brachii 1.1 21.6 4.9 1.3 1.1 1.3 1.4
5 Humerus 0.5 16.4 3.3 1.0 0.8 0.8 1.4
6 Cubital nodes/ 0.9 18.5 4.2 1.3 1.5 1.2 1.3
7 Ulna 0.3 15.1 3.0 1.0 0.9 0.9 1.3
8 Ulna 0.4 14.9 2.6 0.7 1.2 0.5 1.0
9 Radius/Flexor c. 1.1 19.3 0.5 0.2 0.6 1.0 1.1
10 Ulna 0.4 13.3 0.3 0.1 0.9 0.5 0.7
11 Ulna 0.4 11.1 0.6 0.2 1.0 0.3 0.4
Average dose 0.6 16.1 2.2 0.7 1.0 0.8 1.1
Absorbed organ dose ratioa 1.0 28.4 3.9 1.2 1.7 1.5 1.9
aDose compared to the average absorbed organ dose of the radiographic device.
F I G . 4 . Anterior-posterior elbow projections using the Shimadzu FH21-HR radiography device (a), the Siemens Sensation Open MSCT device
(b), the Planmed Verity CBCT device (c) and the NewTom 5G CBCT device HiRes 12 × 8 cm FOV (d), Standard Scan 12 × 8 cm (e), Standard
Scan 15 × 12 cm FOV (f), Standard Scan 18 × 16 cm FOV (g).
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dose attained using the 2D radiographic device. The effective dose
recorded on the Planmed Verity CBCT device (2.6 µSv) was 1.8
times the effective dose measured on the 2D radiographic device.
When compared to the CBCT device, the effective dose attained on
MSCT device was between 6 to 19 times the dose attained using
the NewTom CBCT device and 14 times dose acquired on the Plan-
med Verity CBCT device.
The difference between MSCT effective dose and the average
effective dose of the investigated CBCT protocols was 34.2 µSv.
Although this dose difference may seem negligible, being equivalent
to only 1% (4 days) of the yearly background radiation dose
(3.1 mSv),40 it is still comparable to the effective dose resulting from
two dental panoramic examinations.41 In comparison, the effective
dose difference between the radiography (1.5 µSv) and the CBCT
dose on average (3.2 µSv) was 1.7 µSv, which is comparable to 5 h
of background radiation.
4.B.2 | CBCT protocol comparison
When comparing the CBCT devices the effective doses acquired
using the NewTom 5G “Standard Scan” setting were between 4%
and 22% lower (12 cm × 8 cm, 15 cm × 12 cm, and 18 cm × 16 cm
FOV) than the effective dose measured on the Planmed Verity CBCT
device (FOV 13 cm × 16 cm). These differences can be explained by
the significantly lower tube-current exposure–time product (mAs)
values used in the NewTom 5G device (12 cm × 8 cm FOV:
3.5 mAs, 15 cm × 12 cm FOV: 2.6 mAs and 18 cm × 16 cm FOV:
2.4 mAs) when compared with the Planmed Verity 22.5 mAs value.
However, when compared to the (3.5 mAs) tube current –exposure
product of the “Standard Scan” the “HiRes” mode uses 7.9 times
higher (27.7 mAs) current-exposure product.
Since the dose is linearly dependent on the mAs-value, the effec-
tive dose of the “HiRes” mode should also be 7.9 higher than that of
the “Standard Scan” mode. Surprisingly, the effective dose of the
“HiRes” mode resulted in only a 3.4 times higher value than the
“Standard Scan” mode. This finding is in good agreement with previ-
ous studies.20,21 Surprisingly, when using the larger FOVs on the
NewTom 5G, lower mA values were recorded. This phenomenon
could be caused by the “Safe Beam” technology that automatically
adjusts the exposure current according to the patient’s anatomic
density observed in the scout images. However, when using larger
FOV the elbow shadows a smaller fraction of the detector area that
subsequently causes underestimation of the patient attenuation and
the use of smaller mA value.
It must be noted that both CBCT devices use inherently different
exposure parameters and FOV settings. The NewTom 5G uses a
constant 110 kVp tube voltage and does not offer a manual tube
current adjustment. Furthermore, the NewTom 5G offers different
FOV settings: 18 cm × 16 cm, 15 cm × 12 cm, 12 cm × 8 cm,
8 cm × 8 cm, 15 cm × 5 cm and 6 cm × 6 cm. The Planmed Verity
CBCT device, on the other hand, offers adjustable mA- values rang-
ing between 4.8 and 12 mA but offers only one (13 cm × 16 cm)
FOV.
The low mAs value is an obvious exposure reduction benefit and
subsequently results in a lower effective dose. However, the low
mAs value could have a negative influence on the image quality
since the contrast-to-noise-ratio (CNR) of the image is inversely pro-
portional to the mAs0.5.42 Furthermore, the CNR is known to be clo-
sely associated with the image quality.43–45
In a previous study, Biswas et al.46 quantified the effective dose
from musculoskeletal CT imaging using a GE Lightspeed 16 Qx/I
MSCT device (GE Medical Systems, Milwaukee, WI, USA). The effec-
tive dose was calculated according to a modified protocol derived
from publication SR250 of the National Radiological Protection
Board of the United Kingdom.47
The effective dose they recorded in the elbow area was
0.14 mSv. In our study, the MSCT effective dose was 37 µSv, being
26% of that observed by Biswas et al. The higher tube current used
by Biswas et al. explains the difference in the dose. Another explain-
ing factor for the differences in the effective doses are the dosimet-
ric methods used. The physically realized RANDO phantom and
mathematically modeled phantom are known to cause differences in
the effective dose values.34
In an earlier study, Cross et al.48 investigated the effective dose
in the elbow resulting from conventional radiographic diagnostic
imaging. In their study, the entrance dose was measured and the
effective dose calculated using Monte-Carlo simulations. Their study
resulted in a 0.003 mSv effective dose that was two times the dose
attained in this study. Furthermore, in an earlier study, Huda et al.49
evaluated the effective dose in the elbow area using a radiographic
device (Philips Classic C-850 generator, Eureka ROT-350 x-ray tube).
The effective dose assessment was based on the evaluation of the
imparted energy to the elbow (66 kVp, 10 mAs). Their study resulted
in a 0.69 µSv effective dose using one imaging projection. This result
is in good agreement with the 1.5 µSv effective dose sum for two
projections attained in this study.
One problem faced in the current study is that to date there is
no general consensus on the quantity of red bone marrow in the
arms. Cristy et al.50 reported that red bone marrow is generally not
found in the arms. On the contrary, a recent study by Karampinos
et al.51 reported that red bone marrow can be found in the ends of
the long bones near the joints in healthy adults. Moreover, in a
recent study, Machann et al.34 reported on red and yellow bone
marrow distributions in young children and adults. More specifically,
there is an age-related change in the distribution of active marrow
ranging from a high of as much as 5% in infancy and early childhood
to as low as 0% in adults. Therefore, the 1% red bone marrow con-
tent used in this study elbow of the total RBM was chosen as this
reasonably reflects maximum potential adult marrow content and is
a conservative estimator for the risk calculation.
One difficulty when imaging elbow fractures using an MSCT
device compared with a dedicated extremity CBCT device is the
positioning of the elbow into the FOV without irradiating other body
parts. If the arm would be placed adjacent to the patient’s body, the
internal organs would become exposed by the radiation. This would
increase the effective dose markedly and cause radiation beam
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hardening and respiratory motion artifacts from the torso. In an opti-
mal positioning of the elbow into MSCT device the arm is raised
straight above the patient’s head. This arm positioning, in turn,
according to a study by Chapman et al., causes dose to the bone
marrow in the calvaria and to the brain as the upper part of the
head becomes irradiated by the primary x-ray fan beam10 (Fig. 5.). In
order to evaluate the possible effective dose to the skull during the
elbow CT examination, the head effective dose assessment results
of a previous study by Koivisto et al. were used.41 In their study, the
FOV of a CBCT device was directed in different elevations of the
skull and the effective dose was assessed using MOSFET dosimeter
measurements and PCXMC Monte Carlo simulations respectively.
Using 84 kVp and 145 mAs, the upper part of the skull (elevation
coordinate Z = 95 cm) was estimated to increase the overall effec-
tive dose by 40 µSv.
Although the image quality was not assessed in this study, similar
dose assessments (80–96 kVp and 3.8–12 mA) to those in this study
were undertaken by Huang et al. on an identical Planmed Verity
CBCT device (Table 6). Furthermore, image quality assessments were
also performed. The aim of their study was to evaluate whether it is
justified to use CBCT technology instead of MDCT for extremity
imaging in terms of image quality and radiation dose. The results of
their study demonstrated that the Planmed Verity CBCT images
yielded more diagnostic information than radiographs in 23 out of
51 cases and more diagnostic information than MDCT in one of
seven cases. More specifically, they reported that CBCT images
showed fracture lines that were either not or barely detectable on
radiographs or MDCT device. Moreover, they concluded that the
Planmed Verity CBCT device uses less imaging time than conven-
tional radiographs and generates lower radiation doses than the
Philips and GE MDCT scanners used in their study. It should be
noted, however, that the MDCT devices used in the study by Huang
et al. were not identical to the one used in the current study. How-
ever, the MDCT kVp values were identical to those used in our
study and only minor differences in the mAs values were reported.
Similar image quality versus effective dose findings were reported by
Faccioli et al.12 Furthermore, previous studies by Suojärvi et al. and
De Smet et al reported that CBCT technology was significantly bet-
ter at detecting small bone and joint fractures when compared to
radiographic devices. However, it must be noted that the increased
detection rate of fractures resulted in higher radiation doses.52-54
Future studies are needed to investigate the MSCT and CBCT
iterative reconstruction possibilities to reduce the effective dose
while maintaining good diagnostic image quality.
5 | CONCLUSIONS
When compared with the conventional radiographic device, the stan-
dard MSCT protocol resulted in a 25-fold increase in effective dose.
The standard elbow protocols on the NewTom 5G and Planmed Ver-
ity CBCT devices resulted in a 0.7- to 2.4-fold increase in effective
dose, respectively. The two CBCT devices offered 3D images of the
elbow at a significantly lower dose than the MSCT device.
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